NATIONAL HEALTHCARE CORP
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.52B | $1.31B | $1.14B | $1.09B | $1.07B | $1.03B | $996.4M | $980.3M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $27.50T | $26.24T | $21.41T | $20.7M | $20.2M | $19.9M | $27.0M | $28.7M |
| Operating Income | $128.4M | $89.9M | $57.5M | $31.9M | $50.9M | $48.2M | $49.0M | $56.1M |
| Operating Margin | 8.5% | 6.9% | 5.0% | 2.9% | 4.7% | 4.7% | 4.9% | 5.7% |
| Interest Expense | — | $4.1M | $324.0K | $563.0K | $845.0K | $1.4M | $3.1M | $4.7M |
| Pretax Income | $162.4M | $136.4M | $88.7M | $27.2M | — | — | — | — |
| Income Tax Expense | $39.8M | $34.3M | $23.5M | $7.3M | $11.0M | $10.4M | $20.0M | $16.2M |
| Net Income | $120.0M | $101.9M | $66.8M | $22.4M | $138.6M | $41.9M | $68.2M | $59.0M |
| Net Margin | 7.9% | 7.8% | 5.9% | 2.1% | 12.9% | 4.1% | 6.8% | 6.0% |
| EPS (Basic) | $7.76 | $6.62 | $4.36 | $1.46 | $9.03 | $2.74 | $4.47 | $3.87 |
| EPS (Diluted) | $7.67 | $6.53 | $4.34 | $1.45 | $8.99 | $2.72 | $4.44 | $3.87 |
| Shares Outstanding (Basic) | 15.5M | 15.4M | 15.3M | 15.4M | 15.3M | 15.3M | 15.3M | 15.2M |
| Shares Outstanding (Diluted) | 15.6M | 15.6M | 15.4M | 15.4M | 15.4M | 15.4M | 15.4M | 15.2M |
| Dividends Per Share | $2.53 | $2.42 | $2.34 | $2.26 | $2.11 | $2.08 | $2.06 | $1.98 |